An open label randomized controlled trial of the effects of rice bran oil on cardiometabolic risk factors, lipid peroxidation and antioxidant status in overweight/obese adults with metabolic syndrome.


Journal

Lipids in health and disease
ISSN: 1476-511X
Titre abrégé: Lipids Health Dis
Pays: England
ID NLM: 101147696

Informations de publication

Date de publication:
28 Aug 2024
Historique:
received: 31 05 2024
accepted: 16 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 28 8 2024
Statut: epublish

Résumé

We previously documented the beneficial effects of rice bran oil (RBO) on cardiac function and atherogenic cardiometabolic factors in men with coronary artery disease. Therefore, the existing evidence in this area aims to be expanded by investigating the impact of adding RBO to a daily standard diet on emerging insulin resistance surrogate markers, lipid peroxidation, antioxidant status, and metabolic disturbances in individuals with metabolic syndrome (MetSyn) through an open-label controlled trial. A total of 50 overweight/obese adults (mean body mass index (BMI) = 31.08 kg/m2) with at least 3 MetSyn components were randomly allocated to either the control group, which received a standard diet plan, or the intervention group, which was supplemented with 30 g/d RBO for 8 weeks. BMI, MetSyn components, metabolic score for insulin resistance (METS-IR), triglyceride‒glucose‒BMI (TyG‒BMI), malondialdehyde (MDA), total antioxidant capacity (TAC), and plasma polyphenol levels were measured before and after this open-label trial. Analysis of covariance (ANCOVA) adjusted for baseline values revealed that, compared with patients who received only a standard diet, those who were supplemented with 30 g/d RBO presented significantly lower total cholesterol (P value = 0.005; effect size (ES):-0.92), LDL-cholesterol (P value = 0.048; ES:-0.62), fasting blood glucose (P value = 0.014; ES:-0.77), MDA (P value = 0.002; ES: -1.01), METS-IR (P value < 0.001; ES: -1.24), and TyG-BMI (P value = 0.007; ES:-0.85) after 8 weeks. Additionally, RBO consumption resulted in significantly higher levels of HDL-C (P value = 0.004; ES:0.94) and TAC (P value < 0.0001; ES:2.05). However, no significant changes were noted in BMI, waist circumference, serum triglycerides, plasma polyphenols, or blood pressure. Although the current findings suggest that the hypocholesterolemic, antihyperglycemic, and antioxidative effects of 30 g/d RBO seem to be promising for MetSyn patients, they should be considered preliminary. Therefore, further well-designed clinical trials with larger sample sizes and longer durations are needed to confirm these findings.

Identifiants

pubmed: 39198792
doi: 10.1186/s12944-024-02260-4
pii: 10.1186/s12944-024-02260-4
doi:

Substances chimiques

Rice Bran Oil LZO6K1506A
Antioxidants 0
Malondialdehyde 4Y8F71G49Q
Triglycerides 0
Blood Glucose 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

273

Informations de copyright

© 2024. The Author(s).

Références

Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–607.
pubmed: 3056758 doi: 10.2337/diab.37.12.1595
Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119(10):812–9.
pubmed: 17000207 doi: 10.1016/j.amjmed.2006.02.031
Lakka H-M, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709–16.
pubmed: 12460094 doi: 10.1001/jama.288.21.2709
Laaksonen DE, Lakka H-M, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol. 2002;156(11):1070–7.
pubmed: 12446265 doi: 10.1093/aje/kwf145
Sattar N, Gaw A, Scherbakova O, Ford I, O’Reilly DSJ, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108(4):414–9.
pubmed: 12860911 doi: 10.1161/01.CIR.0000080897.52664.94
Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006;97(2):3–11.
doi: 10.1016/j.amjcard.2005.11.010
Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck JR, Nyaga UF, Ngouo AT, et al. Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract. 2022;188:109924. https://doi.org/10.1016/j.diabres.2022.109924 .
Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 2013;3(1):1.
pubmed: 23720280 pmcid: 4129661
Tylutka A, Morawin B, Walas Ł, Michałek M, Gwara A, Zembron-Lacny A. Assessment of metabolic syndrome predictors in relation to inflammation and visceral fat tissue in older adults. Sci Rep. 2023;13(1):89.
pubmed: 36596839 pmcid: 9810713 doi: 10.1038/s41598-022-27269-6
Esposito K, Giugliano D. The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis. 2004;14(5):228–32.
pubmed: 15673055 doi: 10.1016/S0939-4753(04)80048-6
Quetglas-Llabrés MM, Monserrat-Mesquida M, Bouzas C, Gómez C, Mateos D, Ripoll-Vera T, et al. Inflammatory and Oxidative Stress Markers Related to Adherence to the Mediterranean Diet in Patients with Metabolic Syndrome. Antioxidants (Basel). 2022;11(5):901. https://doi.org/10.3390/antiox11050901 . 
Anaya-Morua W, Villafan-Bernal JR, Ramírez-Moreno E, García-Ortiz H, Martínez-Portilla RJ, Contreras-Cubas C, et al. Total Antioxidant Capacity in Obese and Non-Obese Subjects and Its Association with Anthropo-Metabolic Markers: Systematic Review and Meta-Analysis. Antioxidants. 2023;12(8):1512.
pubmed: 37627507 pmcid: 10451178 doi: 10.3390/antiox12081512
Cravotto G, Binello A, Merizzi G, Avogadro M. Improving solvent-free extraction of policosanol from rice bran by high-intensity ultrasound treatment. Eur J Lipid Sci Technol. 2004;106(3):147–51.
doi: 10.1002/ejlt.200300914
Orthoefer FT, Eastman J. Rice bran oil. Bailey’s industrial oil and fat products. 2005;2(7):465–89.
Sohail M, Rakha A, Butt MS, Iqbal MJ, Rashid S. Rice bran nutraceutics: A comprehensive review. Crit Rev Food Sci Nutr. 2017;57(17):3771–80.
pubmed: 27015585 doi: 10.1080/10408398.2016.1164120
Sivamaruthi BS, Alagarsamy K, Thangaleela S, Bharathi M, Kesika P, Chaiyasut C. Composition, Microbiota, Mechanisms, and Anti-Obesity Properties of Rice Bran. Foods. 2023;12(6):1300.
pubmed: 36981226 pmcid: 10048552 doi: 10.3390/foods12061300
Selim S, Hussein E, Abdel-Megeid NS, Melebary SJ, Al-Harbi MS, Saleh AA. Growth Performance, Antioxidant Activity, Immune Status, Meat Quality, Liver Fat Content, and Liver Histomorphology of Broiler Chickens Fed Rice Bran Oil. Animals (Basel). 2021;11(12):3410. https://doi.org/10.3390/ani11123410 . 
Mahdavi-Roshan M, Salari A, Ghorbani Z, Nikpey Z, Haghighatkhah M, Fakhr Mousavi A, et al. The effects of rice bran oil on left ventricular systolic function, cardiometabolic risk factors and inflammatory mediators in men with coronary artery disease: a randomized clinical trial. Food Funct. 2021;12(10):4446–57.
pubmed: 33881115 doi: 10.1039/D1FO00094B
Mahdavi-Roshan M, Salari A, Vakilpour A, Savar Rakhsh A, Ghorbani Z. Rice bran oil could favorably ameliorate atherogenicity and insulin resistance indices among men with coronary artery disease: post hoc analysis of a randomized controlled trial. Lipids Health Dis. 2021;20(1):153.
pubmed: 34742318 pmcid: 8571839 doi: 10.1186/s12944-021-01584-9
Dietary Guidelines Advisory Committee. Dietary Guidelines for Americans 2010; US Department of Health and Human Services. US Department of Agriculture: Washington, DC; 2010.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
pubmed: 4337382 doi: 10.1093/clinchem/18.6.499
Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533–44.
pubmed: 29535168 doi: 10.1530/EJE-17-0883
Yu X, Wang L, Zhang W, Ming J, Jia A, Xu S, et al. Fasting triglycerides and glucose index is more suitable for the identification of metabolically unhealthy individuals in the Chinese adult population: A nationwide study. J Diabetes Investig. 2019;10(4):1050–8.
pubmed: 30417578 doi: 10.1111/jdi.12975
Er L-K, Wu S, Chou H-H, Hsu L-A, Teng M-S, Sun Y-C, et al. Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals. PloS one. 2016;11(3):e0149731-e.
doi: 10.1371/journal.pone.0149731
Cohen J. The Effect Size. Statistical Power Analysis for the Behavioral Sciences. Abingdon: Routledge; 1988:77–83.
Jolfaie NR, Rouhani MH, Surkan PJ, Siassi F, Azadbakht L. Rice Bran Oil Decreases Total and LDL Cholesterol in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials. Horm Metab Res. 2016;48(7):417–26.
pubmed: 27311126 doi: 10.1055/s-0042-105748
Bumrungpert A, Chongsuwat R, Phosat C, Butacnum A. Rice Bran Oil Containing Gamma-Oryzanol Improves Lipid Profiles and Antioxidant Status in Hyperlipidemic Subjects: A Randomized Double-Blind Controlled Trial. J Altern Complement Med. 2019;25(3):353–8.
pubmed: 30265563 doi: 10.1089/acm.2018.0212
Minhajuddin M, Beg ZH, Iqbal J. Hypolipidemic and antioxidant properties of tocotrienol rich fraction isolated from rice bran oil in experimentally induced hyperlipidemic rats. Food Chem Toxicol. 2005;43(5):747–53.
pubmed: 15778015 doi: 10.1016/j.fct.2005.01.015
Zavoshy R, Noroozi M, Jahanihashemi H. Effect of low calorie diet with rice bran oil on cardiovascular risk factors in hyperlipidemic patients. J Res Med Sci. 2012;17(7):626–31.
pubmed: 23798921 pmcid: 3685777
Lai MH, Chen YT, Chen YY, Chang JH, Cheng HH. Effects of rice bran oil on the blood lipids profiles and insulin resistance in type 2 diabetes patients. J Clin Biochem Nutr. 2012;51(1):15–8.
pubmed: 22798707 doi: 10.3164/jcbn.11-87
Salar A, Faghih S, Pishdad GR. Rice bran oil and canola oil improve blood lipids compared to sunflower oil in women with type 2 diabetes: A randomized, single-blind, controlled trial. J Clin Lipidol. 2016;10(2):299–305.
pubmed: 27055960 doi: 10.1016/j.jacl.2015.11.016
Saphyakhajorn W, Sirirat R, Sapwarobol S. Effect of defatted rice bran supplementation on metabolic parameters and inflammatory status in overweight/obese adults with hypercholesterolemia: a randomized, placebo-controlled intervention. BMC Nutr. 2022;8(1):94.
pubmed: 36045411 pmcid: 9434873 doi: 10.1186/s40795-022-00586-9
Eady S, Wallace A, Willis J, Scott R, Frampton C. Consumption of a plant sterol-based spread derived from rice bran oil is effective at reducing plasma lipid levels in mildly hypercholesterolaemic individuals. Br J Nutr. 2011;105(12):1808–18.
pubmed: 21320365 doi: 10.1017/S0007114510005519
Haldar S, Wong LH, Tay SL, Jacoby JJ, He P, Osman F, et al. Two Blends of Refined Rice Bran, Flaxseed, and Sesame Seed Oils Affect the Blood Lipid Profile of Chinese Adults with Borderline Hypercholesterolemia to a Similar Extent as Refined Olive Oil. J Nutr. 2020;150(12):3141–51.
pubmed: 33188423 doi: 10.1093/jn/nxaa274
Pourrajab B, Sohouli MH, Amirinejad A, Fatahi S, Găman M-A, Shidfar F. The impact of rice bran oil consumption on the serum lipid profile in adults: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2022;62(22):6005–15.
pubmed: 33715544 doi: 10.1080/10408398.2021.1895062
Prasertsri P, Boonla O, Vierra J, Yisarakun W, Koowattanatianchai S, Phoemsapthawee J. Effects of Riceberry Rice Bran Oil Supplementation on Oxidative Stress and Cardiovascular Risk Biomarkers in Older Adults with Prehypertension. Prev Nutr Food Sci. 2022;27(4):365–75.
pubmed: 36721743 pmcid: 9843719 doi: 10.3746/pnf.2022.27.4.365
Rukmini C, Raghuram TC. Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil: a review. J Am Coll Nutr. 1991;10(6):593–601.
pubmed: 1770191 doi: 10.1080/07315724.1991.10718181
Reis N, Castanho A, Lageiro M, Pereira C, Brites CM, Vaz-Velho M. Rice Bran Stabilisation and Oil Extraction Using the Microwave-Assisted Method and Its Effects on GABA and Gamma-Oryzanol Compounds. Foods. 2022;11(7):912.
pubmed: 35406999 pmcid: 8997534 doi: 10.3390/foods11070912
Devarajan S, Singh R, Chatterjee B, Zhang B, Ali A. A blend of sesame oil and rice bran oil lowers blood pressure and improves the lipid profile in mild-to-moderate hypertensive patients. J Clin Lipidol. 2016;10(2):339–49.
pubmed: 27055965 doi: 10.1016/j.jacl.2015.12.011
Purushothama S, Raina PL, Hariharan K. Effect of long term feeding of rice bran oil upon lipids and lipoproteins in rats. Mol Cell Biochem. 1995;146(1):63–9.
pubmed: 7651379 doi: 10.1007/BF00926883
Desjardins LC, Brière F, Tremblay AJ, Rancourt-Bouchard M, Drouin-Chartier JP, Corbeil J, et al. Substitution of dietary monounsaturated fatty acids from olive oil for saturated fatty acids from lard increases low-density lipoprotein apolipoprotein B-100 fractional catabolic rate in subjects with dyslipidemia associated with insulin resistance: a randomized controlled trial. Am J Clin Nutr. 2024;119(5):1270–9.
pubmed: 38518848 doi: 10.1016/j.ajcnut.2024.03.015
Sasaki J, Takada Y, Handa K, Kusuda M, Tanabe Y, Matsunaga A, et al. Effects of gamma-oryzanol on serum lipids and apolipoproteins in dyslipidemic schizophrenics receiving major tranquilizers. Clin Ther. 1990;12(3):263–8.
pubmed: 1974170
Sapwarobol S, Saphyakhajorn W, Astina J. Biological Functions and Activities of Rice Bran as a Functional Ingredient: A Review. Nutr Metab Insights. 2021;14:11786388211058560.
pubmed: 34898989 pmcid: 8655829 doi: 10.1177/11786388211058559
Chou TW, Ma CY, Cheng HH, Chen YY, Lai MH. A rice bran oil diet improves lipid abnormalities and suppress hyperinsulinemic responses in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J Clin Biochem Nutr. 2009;45(1):29–36.
pubmed: 19590704 pmcid: 2704324 doi: 10.3164/jcbn.08-257
Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, et al. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest. 2002;110(1):109–17.
pubmed: 12093894 pmcid: 151029 doi: 10.1172/JCI0215387
Chen CW, Cheng HH. A rice bran oil diet increases LDL-receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J Nutr. 2006;136(6):1472–6.
pubmed: 16702306 doi: 10.1093/jn/136.6.1472
Wang O, Liu J, Cheng Q, Guo X, Wang Y, Zhao L, et al. Effects of ferulic acid and γ-oryzanol on high-fat and high-fructose diet-induced metabolic syndrome in rats. PLoS ONE. 2015;10(2): e0118135.
pubmed: 25646799 pmcid: 4315454 doi: 10.1371/journal.pone.0118135
Ohara K, Uchida A, Nagasaka R, Ushio H, Ohshima T. The effects of hydroxycinnamic acid derivatives on adiponectin secretion. Phytomedicine. 2009;16(2–3):130–7.
pubmed: 19013780 doi: 10.1016/j.phymed.2008.09.012
Sobhy R, Eid M, Zhan F, Liang H, Li B. Toward understanding the in vitro anti-amylolytic effects of three structurally different phytosterols in an aqueous medium using multispectral and molecular docking studies. J Mol Liq. 2019;283:225–34.
Jung EH, Kim SR, Hwang IK, Ha TY. Hypoglycemic effects of a phenolic acid fraction of rice bran and ferulic acid in C57BL/KsJ-db/db mice. J Agric Food Chem. 2007;55(24):9800–4.
pubmed: 17973443 doi: 10.1021/jf0714463
Ahmed MA, Mohamed MA, Rashed LA, Abd Elbast SA, Ahmed EA. Rice Bran Oil Improves Insulin Resistance by Affecting the Expression of Antioxidants and Lipid-Regulatory Genes. Lipids. 2018;53(5):505–15.
pubmed: 30015391 doi: 10.1002/lipd.12045
Pereira C, Lourenço VM, Menezes R, Brites C. Rice Compounds with Impact on Diabetes Control. Foods. 2021;10(9):1992.
Fang F, Kang Z, Wong C. Vitamin E tocotrienols improve insulin sensitivity through activating peroxisome proliferator-activated receptors. Mol Nutr Food Res. 2010;54(3):345–52.
pubmed: 19866471 doi: 10.1002/mnfr.200900119
Vafa M, Haghighat N, Moslehi N, Eghtesadi S, Heydari I. Effect of Tocotrienols enriched canola oil on glycemic control and oxidative status in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled clinical trial. J Res Med Sci. 2015;20(6):540–7.
pubmed: 26600828 pmcid: 4621647 doi: 10.4103/1735-1995.165945
Kuriyan R, Gopinath N, Vaz M, Kurpad AV. Use of rice bran oil in patients with hyperlipidaemia. Natl Med J India. 2005;18(6):292–6.
pubmed: 16483027
Tan SY, Peh E, Siow PC, Marangoni AG, Henry CJ. Effects of the physical-form and the degree-of-saturation of oil on postprandial plasma triglycerides, glycemia and appetite of healthy Chinese adults. Food Funct. 2017;8(12):4433–40.
pubmed: 29090299 doi: 10.1039/C7FO01194F
Yang L, Yang C, Chu C, Wan M, Xu D, Pan D, et al. Beneficial effects of monounsaturated fatty acid-rich blended oils with an appropriate polyunsaturated/saturated fatty acid ratio and a low n-6/n-3 fatty acid ratio on the health of rats. J Sci Food Agric. 2022;102(15):7172–85. https://doi.org/10.1002/jsfa.12083 .
Kalita P, Ahmad AB, Sen S, Deka B, Hazarika QK, Kapil MJ, et al. High-Value Compounds and Bioactivity of Rice Bran, Rice Bran Protein: A review. Recent Adv Food Nutr Agric. 2022. https://doi.org/10.2174/2772574X14666221227151558 . 
Ghatak SB, Panchal SJ. Investigation of the immunomodulatory potential of oryzanol isolated from crude rice bran oil in experimental animal models. Phytother Res. 2012;26(11):1701–8.
pubmed: 22407738 doi: 10.1002/ptr.4627
Saji N, Francis N, Schwarz LJ, Blanchard CL, Santhakumar AB. The Antioxidant and Anti-Inflammatory Properties of Rice Bran Phenolic Extracts. Foods. 2020;9(6):829.

Auteurs

Marjan Mahdavi-Roshan (M)

Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. marjanmahdavi60@gmail.com.
Department of Clinical Nutrition, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. marjanmahdavi60@gmail.com.

Nargeskhatoon Shoaibinobarian (N)

Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Department of Nutrition, School of Medical Sciences and Technologies, Islamic Azad University, Science and Research Branch, Tehran, Iran.

Mehdi Evazalipour (M)

Department of Pharmaceutical Biotechnology, School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran.

Arsalan Salari (A)

Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.

Zeinab Ghorbani (Z)

Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. z.ghorbani.h@gmail.com.
Department of Clinical Nutrition, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. z.ghorbani.h@gmail.com.

Amir Savarrakhsh (A)

Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.

Zahra Ahmadnia (Z)

Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH